Surrey Heartlands

Joint Formulary & PAD

Domperidone - Gastroparesis

You are here : Home > Formulary Search > Domperidone - Gastroparesis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral suspension
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :

Documentation

Evidence Review
Domperidone treatment - Evidence Review - December 2019.pdf

PAD Profile

ChemicalSubstance :
Domperidone
Indication :
Gastroparesis
Group Name :
Keywords :
Brand Names Include :
Motilium
Important Information :
Refer to MHRA cardiac safety alerts. Off label use.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Domperidone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Gastroparesis.

Committee Recommendations (1)

13 Feb 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Area Prescribing Committee recommends the use of domperidone for the treatment of gastroparesis in adults only when prescribed within a secondary care setting.

Domperidone will be considered RED on the traffic light system for this indication.

Prescribers should ensure that the patient understands the risks and consents to using domperidone off-label noting the MHRA alert (updated 2019) - https://www.gov.uk/drug-safety-update/domperidone-risks-of-cardiac-side-effects 

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication